Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...
The Independent on MSN
MPOX symptoms explained: From fever to painful skin rash and blisters
Mpox symptoms explained: From fever to painful skin rash and blisters - A new strain of mpox has been found in England ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback